These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27213814)

  • 21. Rescue of the mature B cell compartment in BAFF-deficient mice by treatment with recombinant Fc-BAFF.
    Swee LK; Tardivel A; Schneider P; Rolink A
    Immunol Lett; 2010 Jun; 131(1):40-8. PubMed ID: 20350570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF.
    Thompson JS; Bixler SA; Qian F; Vora K; Scott ML; Cachero TG; Hession C; Schneider P; Sizing ID; Mullen C; Strauch K; Zafari M; Benjamin CD; Tschopp J; Browning JL; Ambrose C
    Science; 2001 Sep; 293(5537):2108-11. PubMed ID: 11509692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors.
    Zhang X; Park CS; Yoon SO; Li L; Hsu YM; Ambrose C; Choi YS
    Int Immunol; 2005 Jun; 17(6):779-88. PubMed ID: 15908449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B Cell and T Cell Dissimilarities in BAFF-Deficient versus BR3-Deficient C57BL/6 Mice.
    Stohl W; Yu N; Wu Y
    J Immunol; 2022 Dec; 209(11):2133-2140. PubMed ID: 36426969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel bioassay for B-cell activating factor (BAFF) based on expression of a BAFF-receptor ectodomain-tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-2 endodomain fusion receptor in human rhabdomyosarcoma cells.
    McClements M; Williams S; Ball C; Bristow A; Wadhwa M; Meager A
    J Immunol Methods; 2008 Aug; 337(1):63-70. PubMed ID: 18625509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel modality of BAFF-specific inhibitor AMG623 peptibody reduces B-cell number and improves outcomes in murine models of autoimmune disease.
    Hsu H; Khare SD; Lee F; Miner K; Hu YL; Stolina M; Hawkins N; Chen Q; Ho SY; Min H; Xiong F; Boone T; Zack DJ
    Clin Exp Rheumatol; 2012; 30(2):197-201. PubMed ID: 22325420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structure of the BAFF-BAFF-R complex and its implications for receptor activation.
    Kim HM; Yu KS; Lee ME; Shin DR; Kim YS; Paik SG; Yoo OJ; Lee H; Lee JO
    Nat Struct Biol; 2003 May; 10(5):342-8. PubMed ID: 12715002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics.
    Asano R; Shimomura I; Konno S; Ito A; Masakari Y; Orimo R; Taki S; Arai K; Ogata H; Okada M; Furumoto S; Onitsuka M; Omasa T; Hayashi H; Katayose Y; Unno M; Kudo T; Umetsu M; Kumagai I
    MAbs; 2014; 6(5):1243-54. PubMed ID: 25517309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First BAFF gene cloned from an aquatic mammal.
    You F; Ren W; Gu S; Wang W; Zhou L; Zhang Y; Gan W; Chen M
    Gene; 2012 Aug; 504(1):13-21. PubMed ID: 22588026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers.
    Figgett WA; Deliyanti D; Fairfax KA; Quah PS; Wilkinson-Berka JL; Mackay F
    J Autoimmun; 2015 Jul; 61():9-16. PubMed ID: 26027434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective Binding BAFF/APRIL by the In and Outside Conservative Region of BCMA.
    Zheng C; Zhang X; Zhao Z; Hao X; Wei J; Sun J
    Protein Pept Lett; 2017; 24(6):489-494. PubMed ID: 28260502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential Development of Systemic Lupus Erythematosus in NZM 2328 Mice Deficient in Discrete Pairs of BAFF Receptors.
    Jacob CO; Yu N; Sindhava V; Cancro MP; Pawar RD; Putterman C; Stohl W
    Arthritis Rheumatol; 2015 Sep; 67(9):2523-35. PubMed ID: 25989238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties.
    Mackay F; Schneider P
    Cytokine Growth Factor Rev; 2008; 19(3-4):263-76. PubMed ID: 18514565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the marginal zone B cell differentiation activity of BAFF.
    Tardivel A; Tinel A; Lens S; Steiner QG; Sauberli E; Wilson A; Mackay F; Rolink AG; Beermann F; Tschopp J; Schneider P
    Eur J Immunol; 2004 Feb; 34(2):509-18. PubMed ID: 14768056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TACI:Fc scavenging B cell activating factor (BAFF) alleviates ovalbumin-induced bronchial asthma in mice.
    Moon EY; Ryu SK
    Exp Mol Med; 2007 Jun; 39(3):343-52. PubMed ID: 17603288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys.
    Vugmeyster Y; Seshasayee D; Chang W; Storn A; Howell K; Sa S; Nelson T; Martin F; Grewal I; Gilkerson E; Wu B; Thompson J; Ehrenfels BN; Ren S; Song A; Gelzleichter TR; Danilenko DM
    Am J Pathol; 2006 Feb; 168(2):476-89. PubMed ID: 16436662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses.
    Xu S; Lam KP
    Mol Cell Biol; 2001 Jun; 21(12):4067-74. PubMed ID: 11359913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic libraries of shark vNAR domains with different cysteine numbers within the CDR3.
    Cabanillas-Bernal O; Dueñas S; Ayala-Avila M; Rucavado A; Escalante T; Licea-Navarro AF
    PLoS One; 2019; 14(6):e0213394. PubMed ID: 31206542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TACI and BAFF-R mediate isotype switching in B cells.
    Castigli E; Wilson SA; Scott S; Dedeoglu F; Xu S; Lam KP; Bram RJ; Jabara H; Geha RS
    J Exp Med; 2005 Jan; 201(1):35-9. PubMed ID: 15630136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oridonin ameliorates lupus-like symptoms of MRL(lpr/lpr) mice by inhibition of B-cell activating factor (BAFF).
    Zhou L; Sun L; Wu H; Zhang L; Chen M; Liu J; Zhong R
    Eur J Pharmacol; 2013 Sep; 715(1-3):230-7. PubMed ID: 23712004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.